Skip to content

13F-HR filed by M28 Capital Management LP

M28 Capital Management LP filed this 13F-HR for the quarter ended 2024-06-30, filed 2024-08-13, with 11 holding rows worth $77,139,563.

Accession
0000902664-24-005090
Filed
2024-08-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2024

A holdings report, 11 entries on the cover page, a total value of $77,139,563 stated on the cover page (in dollars after the unit check, H1), rows summing to $77,139,563 with VALUE read as dollars as filed, 13F file number 028-21846. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
WAVE LIFE SCIENCES LTD SHSY95308105Stock6,164,548$30,761,095dollars as filed
INVIVYD INC00534A102COMMON STOCK9,248,250$10,173,075dollars as filed
ROCKET PHARMACEUTICALS INC77313F106COM385,680$8,303,690dollars as filed
FRACTYL HEALTH INC35168W103COM1,856,117$7,925,620dollars as filed
SPRINGWORKS THERAPEUTICS INC85205L107COM110,400$4,158,768dollars as filed
SILENCE THERAPEUTICS PLC82686Q101ADS185,100$3,516,900dollars as filed
BRIDGEBIO PHARMA INC10806X102COM121,200$3,069,996dollars as filed
CURIS INC231269309COM421,951$2,911,462dollars as filed
TG THERAPEUTICS INC COM88322Q108Stock161,600$2,874,864dollars as filed
ARROWHEAD PHARMACEUTICALS IN04280A100COM67,400$1,751,726dollars as filed
PROQR THERAPEUTICS NVN71542109SHS EURO1,019,498$1,692,367dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000902664-24-005090this filing2024-08-13acceptance time not in the bulk data set